Q/C TECHNOLOGIES, INC. (QCLS)

↓ Download CSV

CIK 0001321834 · Nasdaq · In Vitro & In Vivo Diagnostic Substances

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

Key ratios (FY2025)

-53.5%
Return on equity
Metric (FY)2025202420232022202120202019201820172016
Revenue$1.58M$1.67M$3.35M
Cost of Revenue$46.5K$93.6K$136.1K$138.7K
Gross Profit$478.7K$127.3K$948.6K$1.88M
Operating Income-$9.85M-$10.17M-$17.12M-$15.28M-$28.81M-$9.49M-$3.47M-$10.06M-$6.61M-$3.33M
Net Income-$11.63M-$23.36M-$4.00M-$15.20M-$29.89M-$9.49M-$3.89M-$10.85M-$7.37M-$3.30M
EPS (Diluted)$-8.66$-1080.87$-5.33$-11.74$-0.85
Total Assets$41.17M$21.42M$17.86M$17.54M$24.81M$676.7K$10.88M$7.81M$9.34M$5.09M
Total Liabilities$16.44M$6.70M$5.09M$2.84M$1.17M$5.93M$1.53M$1.97M$1.79M$1.70M
Shareholders' Equity$21.75M$9.79M$12.37M$14.70M$23.65M-$5.26M-$2.33M$5.83M$7.55M$3.39M
Cash & Equivalents$987.0K$173.2K$2.68M$749.1K$556.0K$148.3K$517.4K$181.8K$438.4K$72.7K
Operating Cash Flow-$9.07M-$8.98M-$12.98M-$12.27M-$19.52M-$4.66M-$3.07M-$8.50M-$5.08M-$4.17M
Capital Expenditures$1.75M$41.7K$207.1K
Shares Outstanding7.69M33.6K2.02M1.32M37.67M17.59M1.74M540.6K5.53M5.45M